日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

No difference in renal function outcomes for patients with oncocytoma managed with active surveillance vs. partial nephrectomy

对于接受积极监测与部分肾切除术治疗的肾嗜酸细胞瘤患者,肾功能预后无差异。

Ginsburg, Kevin B; Strother, Marshall; Schober, Jared P; Bigalli, Alberto Andres Castro; Ruth, Karen; Chen, David Yt; Greenberg, Richard E; Smaldone, Marc C; Viterbo, Rosalia; Uzzo, Robert G; Correa, Andres F; Kutikov, Alexander

Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial

依维莫司治疗期间散发性血管平滑肌脂肪瘤的生长动力学:一项 II 期试验的结果

Geynisman, Daniel M; Kadow, Brian T; Shuch, Brian M; Boorjian, Stephen A; Matin, Surena F; Rampersaud, Edward; Milestone, Barton N; Plimack, Elizabeth R; Zibelman, Matthew R; Kutikov, Alexander; Smaldone, Marc C; Chen, David Yt; Viterbo, Rosalia; Joshi, Shreyas; Greenberg, Richard E; Malizzia, Lois; McGowan, Thomas; Ross, Eric A; Uzzo, Robert G

Neoadjuvant chemotherapy for penile cancer enabling organ preservation: A case of individualized management for bilateral lymph node metastasis and a bulky primary tumor

阴茎癌新辅助化疗可保留器官:双侧淋巴结转移和巨大原发肿瘤个体化治疗病例

Asghar, Aeen M; McIntosh, Andrew G; Kutikov, Alexander; Chen, David Yt; Geynisman, Daniel M

Interest in genomic SNP testing for prostate cancer risk: a pilot survey

对前列腺癌风险基因组SNP检测的兴趣:一项初步调查

Hall, Michael J; Ruth, Karen J; Chen, David Yt; Gross, Laura M; Giri, Veda N

Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer

(124)I-girentuximab在透明细胞肾细胞癌术前诊断中的潜在作用

Smaldone, Marc C; Chen, David Yt; Yu, Jian Q; Plimack, Elizabeth R